Lung Biopsy Systems Market Size

  • Report ID: 4191
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Lung Biopsy Systems Market Size

Lung Biopsy Systems Market size was over USD 3.99 billion in 2024 and is anticipated to cross USD 25.4 billion by 2037, growing at more than 15.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of lung biopsy systems is estimated at USD 5.03 billion.

The reason behind the growth is impelled by a higher prevalence of lung cancer across the globe. As a result, there is a greater need for timely diagnosis which necessitates the use of a lung biopsy system. By extracting samples of lung tissue that may be utilized for molecular testing, a lung biopsy is a generally acknowledged method for identifying pulmonary illnesses. A report published by World Health Organization (WHO) stated that in 2020, around 10 million people died due to lung cancer which was summed up to be 1 in 6 deaths worldwide.

The growing inclination toward minimally invasive surgeries is believed to fuel lung biopsy systems market growth. Minimally invasive surgeries come under the ongoing advancement of the medtech industry and it is performed by delivering less damage to the body with the assistance of enhanced medical imaging equipment services.

Moreover, the use of a robotic-assisted system in minimally invasive lung biopsy enables medical professionals performing the procedure to access all 18 lung regions, enabling the best lung navigation and producing more precise biopsies. This type of treatment is safe, effective, and minimally invasive, which can reduce discomfort, recovery time, and infection risk.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4191
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lung biopsy systems is estimated at USD 5.03 billion.

The lung biopsy systems market size was over USD 3.99 billion in 2024 and is anticipated to cross USD 25.4 billion by 2037, growing at more than 15.3% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of lung cancer across the globe and the growing inclination toward minimally invasive surgeries will boost the market growth.

North America industry is set to hold largest revenue share of 42% by 2037, impelled by growing research and clinical trials to test a new approach to treatment for lung cancer in the region.

The major players in the market are Argon Medical Devices, Inc., Fujifilm Corporation, Cardinal Health, Inc., DTR Medical Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Olympus Corporation, Hologic Inc., Medtronic Limited, Zimmer Biomet Holdings, Inc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample